⌘K
Loading ticker…
Arvinas, Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Arvinas, Inc (ARVN) has a 3-month relative strength percentile of 13 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.5%, relative volume 4.04×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
13 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ARVN is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $20M notional. Top 3 carry $42M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $20M |
| IWMiShares Russell 2000 ETF | 0.02% | $15M |
| VXFVanguard Extended Market ETF | 0.01% | $8M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.25% | $4M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $982K |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $494K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARVN Jan avg: 0.32% median: -1.69% win: 50% σ: 9.10% n: 4 2022-04-12 → 2026-05-29 | ARVN Feb avg: 1.00% median: -0.16% win: 50% σ: 7.20% n: 4 2022-04-12 → 2026-05-29 | ARVN Mar avg: -25.39% median: -15.49% win: 0% σ: 23.74% n: 4 2022-04-12 → 2026-05-29 | ARVN Apr avg: -2.74% median: -6.60% win: 20% σ: 23.54% n: 5 2022-04-12 → 2026-05-29 | ARVN May avg: -14.20% median: -16.71% win: 20% σ: 12.17% n: 5 2022-04-12 → 2026-05-29 | ARVN Jun avg: -0.70% median: 1.59% win: 75% σ: 13.89% n: 4 2022-04-12 → 2026-05-29 (current) | ARVN Jul avg: 7.55% median: 2.21% win: 75% σ: 12.52% n: 4 2022-04-12 → 2026-05-29 | ARVN Aug avg: -1.79% median: -0.51% win: 50% σ: 14.57% n: 4 2022-04-12 → 2026-05-29 | ARVN Sep avg: -5.23% median: -0.39% win: 50% σ: 18.05% n: 4 2022-04-12 → 2026-05-29 | ARVN Oct avg: 5.03% median: 9.52% win: 75% σ: 16.05% n: 4 2022-04-12 → 2026-05-29 | ARVN Nov avg: 11.02% median: 12.61% win: 75% σ: 23.93% n: 4 2022-04-12 → 2026-05-29 | ARVN Dec avg: 9.17% median: -11.20% win: 25% σ: 52.92% n: 4 2022-04-12 → 2026-05-29 |